Physiologic IgG Biodistribution, Transport, and Clearance: Implications for Monoclonal Antibody Products

Preclinical Safety Evaluation of Biopharmaceuticals: A Science-Based Approach to Facilitating Clinical Trials

Volumn , Issue , 2007, Pages 241-276

  Rojko, Jennifer L ^a   Price Schiavi, Shari ^a  

^a CHARLES RIVER LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84891519937     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470292549.ch11     Document Type: Chapter

References (201)

1. Lobo ED, Hansen RJ, Balthasar JP. Antibody pharmacokinetics and pharmacodynamics. J Pharm Sci 2004 ; 93 ( 11 ): 2645-68.
2. Roitt I. Essential Immunology. Oxford: Blackwell Scientifi c, 1994.
3. Brambell FW, Hemmings WA, Morris IG. A theoretical model of gamma-globulin catabolism. Nature 1964 ; 203: 1352-4.
4. Ghetie V, Hubbard JG, Kim JK, Tsen MF, Lee Y, Ward ES. Abnormally short serum half-lives of IgG in beta 2-microglobulin-defi cient mice. Eur J Immunol 1996 ; 26 ( 3 ): 690-6.
5. Junghans RP. Finally! The Brambell receptor (FcRB). Mediator of transmission of immunity and protection from catabolism for IgG. Immunol Res 1997 ; 16 ( 1 ): 29-57.
6. Ghetie V, Ward ES. Transcytosis and catabolism of antibody. Immunol Res 2002 ; 25 ( 2 ): 97-113.
7. Roskos LK, Davis CG, Schwab GM. The clinical pharmacology of therapeutic monoclonal antibodies. Drug Dev Res 2004 ; 61: 108-20.
8. Peterson E, Owens SM, Henry RL. Monoclonal antibody form and function: manufacturing the right antibodies for treating drug abuse. AAPS J 2006 ; 8 ( 2 ): E383-90.
9. Bard P. Medical Physiology, 11th ed. St. Louis: Mosby, 1961.
10. Forsyth RP, Nies AS, Wyler F, Neutze J, Melmon KL. Normal distribution of cardiac output in the unanesthetized, restrined rhesus monkey. J Appl Physiol 1968 ; 25 ( 6 ): 736-41.
11. Venkatachalam MA, Kriz W. Anatomy. In Heppinstall RH, ed. P athology of the Kidney, 4th ed. Boston: Little, Brown, 1992 ; 1-92.
12. Tisher CC, Madsen KM. Anatomy of the kidney. In Brenner MD, ed. Brenner and Rector ' s The Kidney, 5th ed. Philadephia: WB Saunders, 1996 ; 3-71.
13. Matthews DC, Appelbaum FR, Eary JF, et al. Radiolabeled anti-CD45 monoclonal antibodies target lymphohematopoietic tissue in the macaque. Blood 1991 ; 78 ( 7 ): 1864-74.
14. Matthews DC, Appelbaum FR, Eary JF, et al. Phase I study of (131)I-anti-CD45 antibody plus cyclophosphamide and total body irradiation for advanced acute leukemia and myelodysplastic syndrome. Blood 1999 ; 94 ( 4 ): 1237-47.
15. el-Kareh AW, Braunstein SL, Secomb TW. Effect of cell arrangement and interstitial volume fraction on the diffusivity of monoclonal antibodies in tissue. Biophys J 1993 ; 64 ( 5 ): 1638-46.
16. Rippe B, Haraldsson B. Transport of macromolecules across microvascular walls: the two-pore theory. Physiol Rev 1994 ; 74 ( 1 ): 163-219.
17. Simionescu M, Antohe F. Functional ultrastructure of the vascular endothelium: changes in various pathologies. Handb Exp Pharmacol 2006 ;( 176 Pt 1 ): 41-69.
18. Pries AR, Kuebler WM. Normal endothelium. Handb Exp Pharmacol 2006 ; 176 (Pt 1 ): 1-40.
19. Simionescu M, Gafencu A, Antohe F. Transcytosis of plasma macromolecules in endothelial cells: a cell biological survey. Microsc Res Tech 2002 ; 57 ( 5 ): 269-88.
20. Palade GE, Simionescu M, Simionescu N. Structural aspects of the permeability of the microvascular endothelium. Acta Physiol Scand Suppl 1979 ; 463: 11-32.
21. Schnitzer JE. gp60 is an albumin-binding glycoprotein expressed by continuous endothelium involved in albumin transcytosis. Am J Physiol 1992 ; 262 ( 1 Pt 2 ): H246-54.
22. Tiruppathi C, Song W, Bergenfeldt M, Sass P, Malik AB. Gp60 activation mediates albumin transcytosis in endothelial cells by tyrosine kinase-dependent pathway. J Biol Chem 1997 ; 272 ( 41 ): 25968-75.
23. Demignot S, Pimm MV, Baldwin RW. Comparison of biodistribution of 791T/36 monoclonal antibody and its Fab/c fragment in BALB/c mice and nude mice bearing human tumor xenografts. Cancer Res 1990 ; 50 ( 10 ): 2936-42.
24. Tomiyama Y, Kunicki TJ, Zipf TF, Ford SB, Aster RH. Response of human platelets to activating monoclonal antibodies: importance of Fc gamma RII (CD32) phenotype and level of expression. Blood 1992 ; 80 ( 9 ): 2261-8.
25. Thai IM, Ashman LK, Harbour SN, Hogarth PM, Jackson DE. Physical proximity and functional interplay of PECAM-1 with the Fc receptor Fc gamma RIIa on the platelet plasma membrane. Blood 2003 ; 102 ( 10 ): 3637-45.
26. Zhu X, Meng G, Dickinson BL, et al. MHC class I-related neonatal Fc receptor for IgG is functionally expressed in monocytes, intestinal macrophages, and dendritic cells. J Immunol 2001 ; 166 ( 5 ): 3266-76.
27. Groger M, Fischer GF, Wolff K, P etzelbauer P. Immune complexes from vasculitis patients bind to endothelial Fc receptors independent of the allelic polymorphism of FcgammaRIIa. J Invest Dermatol 1999 ; 113 ( 1 ): 56-60.
28. Saji F, Samejima Y, Kamiura S, Koyama M. Dynamics of immunoglobulins at the feto-maternal interface. Rev Reprod 1999 ; 4 ( 2 ): 81-9.
29. Lyden TW, Robinson JM, Tridandapani S, et al. The Fc receptor for IgG expressed in the villus endothelium of human placenta is Fc gamma RIIb2. J Immunol 2001 ; 166 ( 6 ): 3882-9.
30. Minshall RD, Malik AB. Transport across the endothelium: regulation of endothelial permeability. Handb Exp Pharmacol 2006 ; 176 (Pt 1 ): 107-44.
31. Ding BS, Dziubla T, Shuvaev VV, Muro S, Muzykantov VR. Advanced drug delivery systems that target the vascular endothelium. Mol Interv 2006 ; 6 ( 2 ): 98-112.
32. Benarroch EE. Neuron-astrocyte interactions: partnership for normal function and disease in the central nervous system. Mayo Clin Proc 2005 ; 80 ( 10 ): 1326-38.
33. Abbott NJ, Ronnback L, Hansson E. Astrocyte-endothelial interactions at the blood-brain barrier. Nat Rev Neurosci 2006 ; 7 ( 1 ): 41-53.
34. Kim JH, Kim JH, Park JA, et al. Blood-neural barrier: intercellular communication at glio-vascular interface. J Biochem Mol Biol 2006 ; 39 ( 4 ): 339-45.
35. Terasaki T, Ohtsuki S. Brain-to-blood transporters for endogenous substrates and xenobiotics at the blood-brain barrier: an overview of biology and methodology. NeuroRx 2005 ; 2 ( 1 ): 63-72.
36. Jodoin J, Demeule M, Fenart L, et al. P-glycoprotein in blood-brain barrier endothelial cells: interaction and oligomerization with caveolins. J Neurochem 2003 ; 87 ( 4 ): 1010-23.
37. Gosk S, Vermehren C, Storm G, Moos T. Targeting anti-transferrin receptor antibody (OX26) and OX26-conjugated liposomes to brain capillary endothelial cells using in situ perfusion. J Cereb Blood Flow Metab 2004 ; 24 ( 11 ): 1193-204.
38. Ulvestad E, Williams K, Bjerkvig R, Tiekotter K, A ntel J, Matre R. Human microglial cells have phenotypic and functional characteristics in common with both macrophages and dendritic antigen-presenting cells. J Leukoc Biol 1994 ; 56 ( 6 ): 732-40.
39. Carson MJ, Reilly CR, Sutcliffe JG, Lo D. Mature microglia resemble immature antigen-presenting cells. Glia 1998 ; 22 ( 1 ): 72-85.
40. Webster SD, Park M, Fonseca MI, Tenner AJ. Structural and functional evidence for microglial expression of C1qR(P), the C1q receptor that enhances phagocytosis. J Leukoc Biol 2000 ; 67 ( 1 ): 109-16
41. Webster SD, Galvan MD, Ferran E, Garzon-Rodriguez W, Glabe CG, Tenner AJ. Antibody-mediated phagocytosis of the amyloid beta-peptide in microglia is differentially modulated by C1q. J Immunol 2001 ; 166 ( 12 ): 7496-503.
42. Song X, Shapiro S, Goldman DL, Casadevall A, Scharff M, Lee SC. Fcgamma receptor I-and III-mediated macrophage infl ammatory protein 1alpha induction in primary human and murine microglia. Infect Immun 2002 ; 70 ( 9 ): 5177-84.
43. Koenigsknecht-Talboo J, Landreth GE. Microglial phagocytosis induced by fi brillar beta-amyloid and IgGs are differentially regulated by proinfl ammatory cytokines. J Neurosci 2005 ; 25 ( 36 ): 8240-9.
44. Rebe S, Solomon B. Deglycosylation of anti-beta amyloid antibodies inhibits microglia activation in BV-2 cellular model. Am J Alzheimers Dis Other Demen 2005 ; 20 ( 5 ): 303-13.
45. Goldman DL, Casadevall A, Zuckier LS. Pharmacokinetics and biodistribution of a monoclonal antibody to Cryptococcus neoformans capsular polysaccharide antigen in a rat model of cryptococcal meningitis: implications for passive immunotherapy. J Med Vet Mycol 1997 ; 35 ( 4 ): 271-8.
46. Pardridge WM, Buciak JL, Friden PM. Selective transport of an anti-transferrin receptor antibody through the blood-brain barrier in vivo. J Pharmacol Exp Ther 1991 ; 259 ( 1 ): 66-70.
47. Schlachetzki F, Zhu C, Pardridge WM. Expression of the neonatal Fc receptor (FcRn) at the blood-brain barrier. J Neurochem 2002 ; 81 ( 1 ): 203-6.
48. Hofman P, Hoyng P, vanderWerf F, Vrensen GF, Schlingemann RO. Lack of blood-brain barrier properties in microvessels of the prelaminar optic nerve head. Invest Ophthalmol Vis Sci 2001 ; 42 ( 5 ): 895-901.
49. Bours J. The protein distribution of bovine, human and rabbit aqueous humour and the difference in composition before and after disruption of the blood/aqueous humour barrier. Lens Eye Toxic Res 1990 ; 7 ( 3-4 ): 491-503.
50. Verhagen C, Breeboart AC, Kijlstra A. Diffusion of immunoglobulin G from the vascular compartment into the normal rabbit cornea. Invest Ophthalmol Vis Sci 1990 ; 31 ( 8 ): 1519-25.
51. Marie I, Herve F, Lahaxe L, Robaday S, Gerardin E, Levesque H. Intravenous immunoglobulin-associated cranial pachymeningitis. J Intern Med 2006 ; 260 ( 2 ): 164-7.
52. Hadden RD, Gregson NA, Gold R, Smith KJ, Hughes RA. Accumulation of immunoglobulin across the " blood-nerve barrier " in spinal roots in adoptive transfer experimental autoimmune neuritis. Neuropathol Appl Neurobiol 2002 ; 28 ( 6 ): 489-97.
53. Vedeler CA. Demonstration of Fc gamma receptors on human peripheral nerve fi bres. J Neuroimmunol 1987 ; 15 ( 2 ): 207-16.
54. Vedeler CA, Matre R, Kristoffersen EK, Ulvestad E. IgG Fc receptor heterogeneity in human peripheral nerves. Acta Neurol Scand 1991 ; 84 ( 3 ): 177-80.
55. Houston LL, Nowinski RC, Bernstein ID. Specifi c in vivo localization of monoclonal antibodies directed against the Thy 1.1 antigen. J Immunol 1980 ; 125 ( 2 ): 837-43.
56. Badger CC, Krohn KA, Shulman H, Flournoy N, Bernstein ID. Experimental radioimmunotherapy of murine lymphoma with 131I-labeled anti-T-cell antibodies. Cancer Res 1986 ; 46 ( 12 Pt 1 ): 6223-8.
57. Simionescu D, Simionescu M. Differentiated distribution of the cell surface charge on the alveolar-capillary unit. Characteristic paucity of anionic sites on the air-blood barrier. Microvasc Res 1983 ; 25 ( 1 ): 85-100.
58. Lossinsky AS, Shivers RR. Structural pathways for macromolecular and cellular transport across the blood-brain barrier during infl ammatory conditions. Review. Histol Histopathol 2004 ; 19 ( 2 ): 535-64.
59. Svedman C, Yu BB, Ryan TJ, Svensson H. Plasma proteins in a standardised skin mini-erosion (I): permeability changes as a function of time. BMC Dermatol 2002 ; 2: 3.
60. Moldoveanu Z, Epps JM, Thorpe SR, Mestecky J. The sites of catabolism of murine monomeric IgA. J Immunol 1988 ; 141 ( 1 ): 208-13.
61. Mestecky J, Moro I, U nderdown BJ. Mucosal Immunology. Ogra PL, Mestecky J, Lamm ME, Strober W, Bienenstock J, McGhee JR, eds. Mucosal Immunoglobulins, 2nd ed. 1998. London: Academic Press, 1998 ; 133-52.
62. Borvak J, Richardson J, Medesan C, et al. Functional expression of the MHC class I-related receptor, FcRn, in endothelial cells of mice. Int Immunol 1998 ; 10 ( 9 ): 1289-98.
63. Waldmann TA, Strober W. Metabolism of immunoglobulins. P rog Allergy 1969 ; 13: 1-110.
64. Henderson LA, Baynes JW, Thorpe SR. Identifi cation of the sites of IgG catabolism in the rat. Arch Biochem Biophys 1982 ; 215 ( 1 ): 1-11.
65. Olszewski WL, Engeset A. Capillary transport of immunoglobulins and complement proteins to the interstitial fl uid and lymph. Arch Immunol Ther Exp (Warsz) 1978 ; 26 ( 1-6 ): 57-65.
66. Roccatello D, Picciotto G, Ropolo R, et al. Kinetics and fate of IgA-IgG aggregates as a model of naturally occurring immune complexes in IgA nephropathy. Lab Invest 1992 ; 66 ( 1 ): 86-95.
67. Fanger NA, Wardwell K, Shen L, Tedder TF, Guyre PM. Type I (CD64) and type II (CD32) Fc gamma receptor-mediated phagocytosis by human blood dendritic cells. J Immunol 1996 ; 157 ( 2 ): 541-8.
68. Fanger NA, Voigtlaender D, Liu C, et al. C haracterization of expression, cytokine regulation, and effector function of the high affi nity IgG receptor Fc gamma RI (CD64) expressed on human blood dendritic cells. J Immunol 1997 ; 158 ( 7 ): 3090-8.
69. Ravetch JV. Fc receptors. Curr Opin Immunol 1997 ; 9 ( 1 ): 121-5.
70. Guyre CA, Keler T, Swink SL, Vitale LA, Graziano RF, Fanger MW. Receptor modulation by Fc gamma RI-specifi c fusion proteins is dependent on receptor number and modifi ed by IgG. J Immunol 2001 ; 167 ( 11 ): 6303-11.
71. Van WJ, Lipinski P, Abadie A, et al. Antagonistic action of IFN-beta and IFN-gamma on high affi nity Fc gamma receptor expression in healthy controls and multiple sclerosis patients. J Immunol 1998 ; 161 ( 3 ): 1568-74.
72. Uciechowski P, Schwarz M, Gessner JE, Schmidt RE, Resch K, Radeke HH. IFN-gamma induces the high-affi nity Fc receptor I for IgG (CD64) on human glomerular mesangial cells. Eur J Immunol 1998 ; 28 ( 9 ): 2928-35.
73. van Royen-Kerkhof A, Sanders EA, Walraven V, et al. A novel human CD32 mAb blocks experimental immune haemolytic anaemia in FcgammaRIIA transgenic mice. Br J Haematol 2005 ; 130 ( 1 ): 130-7.
74. Wiener E, Dellow RA, Mawas F, Rodeck CH. Role of Fc gamma RIIa (CD32) in IgG anti-RhD-mediated red cell phagocytosis in vitro. Transfus Med 1996 ; 6 ( 3 ): 235-41.
75. Metes D, Ernst LK, Chambers WH, Sulica A, Herberman RB, Morel PA. Expression of functional CD32 molecules on human NK cells is determined by an allelic polymorphism of the FcgammaRIIC gene. Blood 1998 ; 91 ( 7 ): 2369-80.
76. Favaloro EJ. Differential expression of surface antigens on activated endothelium. Immunol Cell Biol 1993 ; 71 (Pt 6 ): 571-81.
77. Coggeshall KM. Regulation of signal transduction by the Fc gamma receptor family members and their involvement in autoimmunity. Curr Dir Autoimmun 2002 ; 5: 1-29.
78. Micouin A, Rouillard D, Bauvois B. Induction of macrophagic differentiation andcytokine secretion by IgG1 molecules in human normal monocytes and myelogenous leukemia cells. Leukemia 1997 ; 11 ( 4 ): 552-60.
79. Ravetch JV, Perussia B. Alternative membrane forms of Fc gamma RIII(CD16) on human natural killer cells and neutrophils. Cell type-specifi c expression of two genes that differ in single nucleotide substitutions. J Exp Med 1989 ; 170 ( 2 ): 481-97.
80. Hisaka H, Kataoka M, Higuchi Y, Matsuura K, Yamamoto S. Close localization of mouse CD14 and CD32/16 in the cell surface of monocytic cell lines. Pathobiology 1999 ; 67 ( 2 ): 92-8.
81. de AB, Mueller AL, Verbeek S, Sandor M, Lynch RG. A regulatory role for Fcgamma receptors CD16 and CD32 in the development of murine B cells. Blood 1998 ; 92 ( 8 ): 2823-9.
82. Delire M. Different modes of action of high-dose immunoglobulins in rheumatoid arthritis. Acta Univ Carol [Med] (Praha) 1994 ;40(1-4): 95-9.
83. Muller C, Traindl O, Schwarz M, et al. Increased Fc-receptor-mediated clearance via reticuloendothelial system in patients with nephrotic syndrome. Nephron 1991 ; 58 ( 2 ): 150-4.
84. Anderson CL, Abraham GN. Characterization of the Fc receptor for IgG on a human macrophage cell line, U937. J Immunol 1980 ; 125 ( 6 ): 2735-41.
85. McCool D, Birshtein BK, Painter RH. Structural requirements of immunoglobulin G for binding to the Fc gamma receptors of the human tumor cell lines U937, HL-60, ML-1, and K562. J Immunol 1985 ; 135 ( 3 ): 1975-80.
86. Canfi eld SM, Morrison SL. The binding affi nity of human IgG for its high affi nity Fc receptor is determined by multiple amino acids in the CH2 domain and is modulated by the hinge region. J Exp Med 1991 ; 173 ( 6 ): 1483-91.
87. Chappel MS, Isenman DE, Everett M, Xu YY, Dorrington KJ, Klein MH. Identifi cation of the Fc gamma receptor class I binding site in human IgG through the use of recombinant IgG1/IgG2 hybrid and point-mutated antibodies. Proc Natl Acad Sci USA 1991 ; 88 ( 20 ): 9036-40.
88. Chappel MS, Isenman DE, Oomen R, Xu YY, Klein MH. Identifi cation of a secondary Fc gamma RI binding site within a genetically engineered human IgG antibody. J Biol Chem 1993 ; 268 ( 33 ): 25124-31.
89. Tan LK, Shopes RJ, Oi VT, Morrison SL. Infl uence of the hinge region on complement activation, C1q binding, and segmental fl exibility in chimeric human immunoglobulins. Proc Natl Acad Sci USA 1990 ; 87 ( 1 ): 162-6.
90. Morgan A, Jones ND, Nesbitt AM, Chaplin L, Bodmer MW, Emtage JS. The N-terminal end of the CH2 domain of chimeric human IgG1 anti-HLA-DR is necessary for C1q, Fc gamma RI and Fc gamma RIII binding. Immunology 1995 ; 86 ( 2 ): 319-24.
91. Kim MK, Huang ZY, Hwang PH, et al. Fcgamma receptor transmembrane domains: role in cell surface expression, gamma chain interaction, and phagocytosis. Blood 2003 ; 101 ( 11 ): 4479-84.
92. Kim JK, Firan M, Radu CG, Kim CH, Ghetie V, W ard ES. Mapping the site on human IgG for binding of the MHC class I-related receptor, FcRn. Eur J Immunol 1999 ; 29 ( 9 ): 2819-25.
93. Kim JK, Tsen MF, Ghetie V, Ward ES. Identifying amino acid residues that infl uence plasma clearance of murine IgG1 fragments by site-directed mutagenesis. Eur J Immunol 1994 ; 24 ( 3 ): 542-8.
94. Popov S, Hubbard JG, Kim J, Ober B, Ghetie V, Ward ES. The stoichiometry and affi nity of the interaction of murine Fc fragments with the MHC class I-related receptor, FcRn. Mol Immunol 1996 ; 33 ( 6 ): 521-30.
95. Parren PW, Warmerdam PA, Boeije LC, Capel PJ, van de Winkel JG, Aarden LA. Characterization of IgG FcR-mediated proliferation Of human T cells induced by mouse and Human anti-CD3 monoclonal antibodies. Identifi cation of a functional polymorphism to human IgG2 anti-CD3. J Immunol 1992 ; 148 ( 3 ): 695-701.
96. Wu J, Edberg JC, Redecha PB, et al. A novel polymorphism of FcgammaRIIIa (CD16) alters receptor function and predisposes to autoimmune disease. J Clin Invest 1997 ; 100 ( 5 ): 1059-70.
97. Koene HR, Kleijer M, Algra J, Roos D, von dem Borne AE, De HM. Fc gammaRIIIa-158V/F polymorphism infl uences the binding of IgG by natural killer cell Fc gammaRIIIa, independently of the Fc gammaRIIIa-48L/R/H phenotype. Blood 1997 ; 90 ( 3 ): 1109-14.
98. Cartron G, Dacheux L, Salles G, et al. Therapeutic activity of humanized anti-CD20 monoclonal antibody and polymorphism in IgG Fc receptor Fc gamma RIIIa gene. Blood 2002 ; 99 ( 3 ): 754-8.
99. Su K, Wu J, Edberg JC, McKenzie SE, Kimberly RP. Genomic organization of classical human low-affi nity Fc gamma receptor genes. Genes Immun 2002 ; 3 Suppl 1: S51-6.
100. Haagen IA, Geerars AJ, Clark MR, van de Winkel JG. Interaction of human monocyte Fc gamma receptors with rat IgG2b: a new indicator for the Fc gamma RIIa (R-H131) polymorphism. J Immunol 1995 ; 154 ( 4 ): 1852-60.
101. Medesan C, Matesoi D, Radu C, Ghetie V, Ward ES. Delineation of the amino acid residues involved in transcytosis and catabolism of mouse IgG1. J Immunol 1997 ; 158 ( 5 ): 2211-7.
102. Mattes MJ. Biodistribution of antibodies after intraperitoneal or intravenous injection and effect of carbohydrate modifi cations. J Natl Cancer Inst 1987 ; 79 ( 4 ): 855-63.
103. Wright A, Morrison SL. Effect of altered CH2-associated carbohydrate structure on the functional properties and in vivo fate of chimeric mouse-human immunoglobulin G1. J Exp Med 1994 ; 180 ( 3 ): 1087-96.
104. Wright A, Sato Y, Okada T, Chang K, Endo T, Morrison S. In vivo traffi cking and catabolism of IgG1 antibodies with Fc associated carbohydrates of differing structure. Glycobiology 2000 ; 10 ( 12 ): 1347-55.
105. Lennartz MR, Cole FS, Shepherd VL, Wileman TE, Stahl PD. Isolation and characterization of a mannose-specifi c endocytosis receptor from human placenta. J Biol Chem 1987 ; 262 ( 21 ): 9942-4.
106. Stahl PD. The mannose receptor and other macrophage lectins. Curr Opin Immunol 1992 ; 4 ( 1 ): 49-52.
107. Dong X, Storkus WJ, Salter RD. Binding and uptake of agalactosyl IgG by mannose receptor on macrophages and dendritic cells. J Immunol 1999 ; 163 ( 10 ): 5427-34.
108. Groenink J, Spijker J, van den Herik-Oudijk IE, et al. On the interaction between agalactosyl IgG and Fc gamma receptors. Eur J Immunol 1996 ; 26 ( 6 ): 1404-7.
109. Dickinson BL, Badizadegan K, Wu Z, et al. Bidirectional FcRn-dependent IgG transport in a polarized human intestinal epithelial cell line. J Clin Invest 1999 ; 104 ( 7 ): 903-11.
110. Kobayashi N, Suzuki Y, Tsuge T, Okumura K, Ra C, Tomino Y. FcRn-mediated transcytosis of immunoglobulin G in human renal proximal tubular epithelial cells. Am J Physiol Renal Physiol 2002 ; 282 ( 2 ): F358-65.
111. Simister NE, Mostov KE. Cloning and expression of the neonatal rat intestinal Fc receptor, a major histocompatibility complex class I antigen homolog. Cold Spring Harb Symp Quant Biol 1989 ; 54 (Pt 1 ): 571-80.
112. Simister NE, Mostov KE. An Fc receptor structurally related to MHC class I antigens. Nature 1989 ; 337 ( 6203 ): 184-7.
113. Junghans RP, Anderson CL. The protection receptor for IgG catabolism is the beta2-microglobulin-containing neonatal intestinal transport receptor. Proc Natl Acad Sci USA 1996 ; 93 ( 11 ): 5512-6.
114. Story CM, Mikulska JE, Simister NE. A major histocompatibility complex class I-like Fc receptor cloned from human placenta: possible role in transfer of immunoglobulin G from mother to fetus. J Exp Med 1994 ; 180 ( 6 ): 2377-81.
115. Mikulska JE, Pablo L, Canel J, Simister NE. Cloning and analysis of the gene encoding the human neonatal Fc receptor. Eur J Immunogenet 2000 ; 27 ( 4 ): 231-40.
116. Haymann JP, Levraud JP, Bouet S, et al. Characterization and localization of the neonatal Fc receptor in adult human kidney. J Am Soc Nephrol 2000 ; 11 ( 4 ): 632-9.
117. Zhu X, Peng J, Raychowdhury R, Nakajima A, Lencer WI, Blumberg RS. The heavy chain of neonatal Fc receptor for IgG is sequestered in endoplasmic reticulum by forming oligomers in the absence of beta2-microglobulin association. Biochem J 2002 ; 367 (Pt 3 ): 703-14.
118. Teter K, Chandy G, Quinones B, Pereyra K, Machen T, Moore HP. Cellubrevin-targeted fl uorescence uncovers heterogeneity in the recycling endosomes. J Biol Chem 1998 ; 273 ( 31 ): 19625-33.
119. Ober RJ, Martinez C, Lai X, Zhou J, Ward ES. Exocytosis of IgG as mediated by the receptor, FcRn: an analysis at the single-molecule level. Proc Natl Acad Sci USA 2004 ; 101 ( 30 ): 11076-81.
120. Ober RJ, Martinez C, Vaccaro C, Zhou J, Ward ES. Visualizing the site and dynamics of IgG salvage by the MHC class I-related receptor, FcRn. J Immunol 2004 ; 172 ( 4 ): 2021-9.
121. Vaccaro C, Zhou J, O ber RJ, Ward ES. Engineering the Fc region of immunoglobulin G to modulate in vivo antibody levels. Nat Biotechnol 2005 ; 23 ( 10 ): 1283-8.
122. Brambell FW, Hemmings WA, Oakley CL, Porter RR. The relative transmission of the fractions of papain hydrolyzed homologous gamma-globulin from the uterine cavity to the foetal circulation in the rabbit. Proc R Soc Lond B Biol Sci 1960 ; 151: 478-82.
123. Brambell FW. The transmission of immune globulins from the mother to the foetal and newborn young. Proc Nutr Soc 1969 ; 28 ( 1 ): 35-41.
124. Telleman P, Junghans RP. The role of the Brambell receptor (FcRB) in liver: protection of endocytosed immunoglobulin G (IgG) from catabolism in hepatocytes rather than transport of IgG to bile. Immunology 2000 ; 100 ( 2 ): 245-51.
125. Antohe F, Radulescu L, Gafencu A, Ghetie V, Simionescu M. Expression of functionally active FcRn and the differentiated bidirectional transport of IgG in human placental endothelial cells. Hum Immunol 2001 ; 62 ( 2 ): 93-105.
126. Stevenson GT, Anderson VA, Leong WS. Engineered antibody for treating lymphoma. Recent Results Cancer Res 2002 ; 159: 104-12. Tannock IF, Rotin D. Acid pH in tumors and its potential for therapeutic exploitation. Cancer Res 1989 ; 49 ( 16 ): 4373-84.
127. Kristoffersen EK, Matre R. Co-localization of beta 2-microglobulin and IgG in human placental syncytiotrophoblasts. Eur J Immunol 1996 ; 26 ( 2 ): 505-7.
128. Junghans RP, Carrasquillo JA, Waldmann TA. Impact of antigenemia on the bioactivity of infused anti-Tac antibody: implications for dose selection in antibody immunotherapies. Proc Natl Acad Sci USA 1998 ; 95 ( 4 ): 1752-7.
129. Hobbs SM, Jackson LE, Hoadley J. Interaction of aglycosyl immunoglobulins with the IgG Fc transport receptor from neonatal rat gut: comparison of deglycosylation by tunicamycin treatment and genetic engineering. Mol Immunol 1992 ; 29 ( 7-8 ): 949-56.
130. Perez JH, Wight DG, Wyatt JI, Van SM, Mullock BM, Luzio JP. The polymeric immunoglobulin A receptor is present on hepatocytes in human liver. Immunology 1989 ; 68 ( 4 ): 474-8.
131. Tourville DR, Adler RH, Bienenstock J, Tomasi TB, Jr. The human secretory immunoglobulin system: immunohistoligical localization of gamma A, secretory " piece, " and lactoferrin in normal human tissues. J Exp Med 1969 ; 129 ( 2 ): 411-29.
132. Tourville DR, Tomasi TB, Jr. Selective transport of gamma A. Proc Soc Exp Biol Med 1969 ; 132 ( 2 ): 473-7.
133. Takahashi I, Nakane PK, Brown WR. Ultrastructural events in the translocation of polymeric IgA by rat hepatocytes. J Immunol 1982 ; 128 ( 3 ): 1181-7.
134. Schiff JM, Fisher MM, Jones AL, Underdown BJ. Human IgA as a heterovalent ligand: switching from the asialoglycoprotein receptor to secretory component during transport across the rat hepatocyte. J Cell Biol 1986 ; 102 ( 3 ): 920-31.
135. Kaetzel CS, Robinson JK, Lamm ME. Epithelial transcytosis of monomeric IgA and IgG cross-linked through antigen to polymeric IgA. A role for monomeric antibodies in the mucosal immune system. J Immunol 1994 ; 152 ( 1 ): 72-6.
136. Hunziker W, Mellman I. Expression of macrophage-lymphocyte Fc receptors in Madin-Darby canine kidney cells: polarity and transcytosis differ for isoforms with or without coated pit localization domains. J Cell Biol 1989 ; 109 ( 6 Pt 2 ): 3291-302.
137. Hunziker W, Male P, Mellman I. Differential microtubule requirements for transcytosis in MDCK cells. EMBO J 1990 ; 9 ( 11 ): 3515-25.
138. Gurevich P, Zusman I, Moldavsky M, et al. Secretory immune system in human intrauterine development: immunopathomorphological analysis of the role of secretory component (pIgR/SC) in immunoglobulin transport (review). Int J Mol Med 2003 ; 12 ( 3 ): 289-97.
139. Leung JC, Tsang AW, Chan DT, Lai KN. Absence of CD89, polymeric immunoglobulin receptor, and asialoglycoprotein receptor on human mesangial cells. J Am Soc Nephrol 2000 ; 11 ( 2 ): 241-9.
140. Ball JM, Moldoveanu Z, Melsen LR, et al. A polarized human endometrial cell line that binds and transports polymeric IgA. In Vitro Cell Dev Biol Anim 1995 ; 31 ( 3 ): 196-206.
141. Underdown BJ, Schiff JM. Immunoglobulin A: strategic defense initiative at the mucosal surface. Annu Rev Immunol 1986 ; 4: 389-417.
142. Manning RJ, Walker PG, Carter L, Barrington PJ, Jackson GD. Studies on the origins of biliary immunoglobulins in rats. Gastroenterology 1984 ; 87 ( 1 ): 173-9.
143. Mullock BM, Shaw LJ, Fitzharris B, et al. Sources of proteins in human bile. Gut 1985 ; 26 ( 5 ): 500-9.
144. Blumberg RS, Koss T, Story CM, et al. A major histocompatibility complex class I-related Fc receptor for IgG on rat hepatocytes. J Clin Invest 1995 ; 95 ( 5 ): 2397-402.
145. Sheff DR, Daro EA, Hull M, Mellman I. The receptor recycling pathway contains two distinct populations of early endosomes with different sorting functions. J Cell Biol 1999 ; 145 ( 1 ): 123-39.
146. Zhang JR, Mostov KE, Lamm ME, et al. The polymeric immunoglobulin receptor translocates pneumococci across human nasopharyngeal epithelial cells. Cell 2000 ; 102 ( 6 ): 827-37.
147. Elm C, Braathen R, Bergmann S, et al. Ectodomains 3 and 4 of human polymeric Immunoglobulin receptor (hpIgR) mediate invasion of Streptococcus pneumoniae into the epithelium. J Biol Chem 2004 ; 279 ( 8 ): 6296-304.
148. Sixbey JW, Yao QY. Immunoglobulin A-induced shift of Epstein-Barr virus tissue tropism. Science 1992 ; 255 ( 5051 ): 1578-80.
149. Gan YJ, Chodosh J, Morgan A, Sixbey JW. Epithelial cell polarization is a determinant in the infectious outcome of immunoglobulin A-mediated entry by Epstein-Barr virus. J Virol 1997 ; 71 ( 1 ): 519-26.
150. Aarli A, Matre R, Thunold S. IgG Fc receptors on epithelial cells of distal tubuli and on endothelial cells in human kidney. Int Arch Allergy Appl Immunol 1991 ; 95 ( 1 ): 64-9.
151. Kuhn K, Stolte H, Reale E. The fi ne structure of the kidney of the hagfi sh ( Myxine glutinosa L.): A thin section and freeze-fracture study. Cell Tissue Res 1975 ; 164 ( 2 ): 201-13.
152. Latta H. An approach to the structure and function of the glomerular mesangium. J Am Soc Nephrol 1992 ;2( 10 Suppl): S65-73.
153. Tencer J, Frick IM, Oquist BW, Alm P, Rippe B. Size-selectivity of the glomerular barrier to high molecular weight proteins: upper size limitations of shunt pathways. Kidney Int 1998 ; 53 ( 3 ): 709-15.
154. Radeke HH, Gessner JE, Uciechowski P, Magert HJ, Schmidt RE, Resch K. Intrinsic human glomerular mesangial cells can express receptors for IgG complexes (hFc gamma RIII-A) and the associated Fc epsilon RI gamma-chain. J Immunol 1994 ; 153 ( 3 ): 1281-92.
155. Gomez-Guerrero C, Hernandez-Vargas P, Lopez-Franco O, Ortiz-Munoz G, Egido J. Mesangial cells and glomerular infl ammation: from the pathogenesis to novel therapeutic approaches. Curr Drug Targets Infl amm Allergy 2005 ; 4 ( 3 ): 341-51.
156. Mauer SM, Fish AJ, Blau EB, Michael AF. The glomerular mesangium. I. Kinetic studies of macromolecular uptake in normal and nephrotic rats. J Clin Invest 1972 ; 51 ( 5 ): 1092-101.
157. Thompson EM, Evans DJ. Association of mesangial IgM with IgM deposits in the macula densa: an indication of non-specifi c macromolecule transport rather than immune reactant? Nephrol Dial Transplant 2001 ; 16 ( 9 ): 1910-3.
158. Junghans RP, Waldmann TA. Metabolism of Tac (IL2Ralpha): physiology of cell surface shedding and renal catabolism, and suppression of catabolism by antibody binding. J Exp Med 1996 ; 183 ( 4 ): 1587-602.
159. Clyne PS, Kulczycki A, Jr. Human breast milk contains bovine IgG. Relationship to infant colic? Pediatrics 1991 ; 87 ( 4 ): 439-44.
160. Cianga P, Cianga C, Cozma L, Ward ES, Carasevici E. The MHC class I related Fc receptor, FcRn, is expressed in the epithelial cells of the human mammary gland. Hum Immunol 2003 ; 64 ( 12 ): 1152-9.
161. Takaya R, Fukaya T, Sasano H, Suzuki T, Tamura M, Yajima A. Macrophages in normal cycling human ovaries; immunohistochemical localization and characterization. Hum Reprod 1997 ; 12 ( 7 ): 1508-12.
162. Leach JL, Sedmak DD, Osborne JM, Rahill B, Lairmore MD, Anderson CL. Isolation from human placenta of the IgG transporter, FcRn, and localization to the syncytiotrophoblast: implications for maternal-fetal antibody transport. J Immunol 1996 ; 157 ( 8 ): 3317-22.
163. Kristoffersen EK. Human placental Fc gamma-binding proteins in the maternofetal transfer of IgG. APMIS Suppl 1996 ; 64: 5-36.
164. Einhorn MS, Granoff DM, Nahm MH, Quinn A, Shackelford PG. Concentrations of antibodies in paired maternal and infant sera: relationship to IgG subclass. J Pediatr 1987 ; 111 ( 5 ): 783-8.
165. Malek A, Sager R, Schneider H. Transport of proteins across the human placenta. Am J Reprod Immunol 1998 ; 40 ( 5 ): 347-51.
166. Malek A. Ex vivo human placenta models: transport of immunoglobulin G and its subclasses. Vaccine 2003 ; 21 ( 24 ): 3362-4.
167. Eaton BM, Oakey MP. Image analysis of protein profi les from paired microvillous and basal syncytiotrophoblast plasma membranes from term human placenta and characterization of IgG binding to membrane vesicles. Placenta 1997 ; 18 ( 7 ): 569-76.
168. Kutteh WH, Moldoveanu Z, Mestecky J. Mucosal immunity in the female reproductive tract: correlation of immunoglobulins, cytokines, and reproductive hormones in human cervical mucus around the time of ovulation. AIDS Res Hum Retroviruses 1998 ; 14 Suppl 1: S51-5.
169. Moldoveanu Z, Huang WQ, Kulhavy R, Pate MS, Mestecky J. Human male genital tract secretions: both mucosal and systemic immune compartments contribute to the humoral immunity. J Immunol 2005 ; 175 ( 6 ): 4127-36.
170. Delacroix DL, Marchandise FX, Francis C, Sibille Y. Alpha-2-macroglobulin, monomeric and polymeric immunoglobulin A, and immunoglobulin M in bronchoalveolar lavage. Am Rev Respir Dis 1985 ; 132 ( 4 ): 829-35.
171. Bignon J, Jaurand MC, Pinchon MC, Sapin C, Warnet JM. Immunoelectron microscopic and immunochemical demonstrations of serum proteins in the alveolar lining material of the rat lung. Am Rev Respir Dis 1976 ; 113 ( 2 ): 109-20.
172. Kim KJ, Malik AB. Protein transport across the lung epithelial barrier. Am J Physiol Lung Cell Mol Physiol 2003 ; 284 ( 2 ): L247-59.
173. Spiekermann GM, Finn PW, Ward ES, et al. Receptor-mediated immunoglobulin G transport across mucosal barriers in adult life: functional expression of FcRn in the mammalian lung. J Exp Med 2002 ; 196 ( 3 ): 303-10.
174. Dumont JA, Bitonti AJ, Clark D, Evans S, Pickford M, Newman SP. Delivery of an erythropoietin-Fc fusion protein by inhalation in humans through an immunoglobulin transport pathway. J Aerosol Med 2005 ; 18 ( 3 ): 294-303.
175. Cauza K, Hinterhuber G, Dingelmaier-Hovorka R, et al. Expression of FcRn, the MHC class I-related receptor for IgG, in human keratinocytes. J Invest Dermatol 2005 ; 124 ( 1 ): 132-9.
176. Brown WR, Kloppel TM. The role of the liver in translocation of IgA into the gastrointestinal tract. Immunol Invest 1989 ; 18 ( 1-4 ): 269-85.
177. Brown WR, Kloppel TM. The liver and IgA: immunological, cell biological and clinical implications. Hepatology 1989 ; 9 ( 5 ): 763-84.
178. Raju TS, Briggs JB, Chamow SM, Winkler ME, Jones AJ. Glycoengineering of therapeutic glycoproteins: in vitro galactosylation and sialylation of glycoproteins with terminal N-acetylglucosamine and galactose residues. Biochemistry 2001 ; 40 ( 30 ): 8868-76.
179. Hurlimann J. Immunoglobulin synthesis and transport by human salivary glands. Immunological mechanisms of the mucous membranes. Curr Top Pathol 1971 ; 55: 69-108.
180. Proctor GB, Carpenter GH. Chewing stimulates secretion of human salivary secretory immunoglobulin A. J Dent Res 2001 ; 80 ( 3 ): 909-13.
181. Strober W, Blaese RM, Waldmann TA. The origin of salivary IgA. J Lab Clin Med 1970 ; 75 ( 5 ): 856-62.
182. Malamud D. Oral diagnostic testing for detecting human immunodefi ciency virus-1 antibodies: a technology whose time has come. Am J Med 1997 ; 102 ( 4A ): 9-14.
183. Takahashi K, Mooney J, Frandsen EV, Kinane DF. IgG and IgA subclass mRNA-bearing plasma cells in periodontitis gingival tissue and immunoglobulin levels in the gingival crevicular fl uid. Clin Exp Immunol 1997 ; 107 ( 1 ): 158-65.
184. Hochman N, Zakay-Rones Z, Shohat H, et al. Antibodies to cytomegalo and Epstein-Barr viruses in human saliva and gingival fl uid. New Microbiol 1998 ; 21 ( 2 ): 131-9.
185. Brandtzaeg P. Human secretory immunoglobulins. II. Salivary secretions from individuals with selectively excessive or defective synthesis of serum immunoglobulins. Clin Exp Immunol 1971 ; 8 ( 1 ): 69-85.
186. Newcomb RW, Ishizaka K, DeVald BL. Human IgG and IgA diphtheria antitoxins in serum, nasal fl uids and saliva. J Immunol 1969 ; 103 ( 2 ): 215-24.
187. Prigent-Delecourt L, Coffi n B, Colombel JF, Dehennin JP, Vaerman JP, Rambaud JC. Secretion of immunoglobulins and plasma proteins from the colonic mucosa: an in vivo study in man. Clin Exp Immunol 1995 ; 99 ( 2 ): 221-5.
188. Zimmer KP, Scheumann GF, Bramswig J, Bocker W, Harms E, Schmid KW. Ultrastructural localization of IgG and TPO in autoimmune thyrocytes referring to the transcytosis of IgG and the antigen presentation of TPO. Histochem Cell Biol 1997 ; 107 ( 2 ): 115-20.
189. Zimmer KP, Schmid KW, Bocker W, et al. Transcytosis of IgG from the basolateral to the apical membrane of human thyrocytes in autoimmune thyroid disease. Curr Top Pathol 1997 ; 91: 117-28.
190. Estienne V, Duthoit C, Reichert M, et al. Androgen-dependent expression of FcgammaRIIB2 by thyrocytes from patients with autoimmune Graves ' disease: a possible molecular clue for sex dependence of autoimmune disease. FASEB J 2002 ; 16 ( 9 ): 1087-92.
191. Barrett JS, Wagner JG, Fisher SJ, Wahl RL. Effect of intraperitoneal injection volume and antibody protein dose on the pharmacokinetics of intraperitoneally administered IgG2a kappa murine monoclonal antibody in the rat. Cancer Res 1991 ; 51 ( 13 ): 3434-44.
192. Feriani M, Biasioli S, Chiaramonte S, et al. Anatomical bases of peritoneal permeability: a reappraisal. Anatomy of peritoneum. Int J Artif Organs 1982 ; 5 ( 6 ): 345-8.
193. Flessner MF, Dedrick RL, Reynolds JC. Bidirectional peritoneal transport of immunoglobulin in rats: tissue concentration profi les. Am J Physiol 1992 ; 263 ( 1 Pt 2 ): F15-23.
194. Flessner MF, Dedrick RL, Reynolds JC. Bidirectional peritoneal transport of immunoglobulin in rats: compartmental kinetics. Am J Physiol 1992 ; 262 ( 2 Pt 2 ): F275-87.
195. Flessner MF, Dedrick RL. Monoclonal antibody delivery to intraperitoneal tumors in rats: effects of route of administration and intraperitoneal solution osmolality. Cancer Res 1994 ; 54 ( 16 ): 4376-84.
196. Flessner MF. The role of extracellular matrix in transperitoneal transport of water and solutes. Perit Dial Int 2001 ; 21 Suppl 3: S24-9.
197. Rosengren BI, Carlsson O, Venturoli D, al RO, Rippe B. Transvascular passage of macromolecules into the peritoneal cavity of normo-and hypothermic rats in vivo: active or passive transport? J Vasc Res 2004 ; 41 ( 2 ): 123-30.
198. Krediet RT, Koomen GC, Vlug A, et al. IgG subclasses in CAPD patients. Perit Dial Int 1996 ; 16 ( 3 ): 288-94.
199. Yokoyama I, Waxman F. Isotypic and clonal variations in the interactions between model monoclonal immune complexes and the human erythrocyte CR1 receptor. Mol Immunol 1992 ; 29 ( 7-8 ): 935-47.
200. Kavai M, Rasmussen JM, Baatrup G, Z sindely A, Svehag SE. Ineffi cient binding of IgM immune complexes to erythrocyte C3b-C4b receptors (CR1) and weak incorporation of C3b-iC3b into the complexes. Scand J Immunol 1988 ; 28 ( 1 ): 123-8.
201. Marzocchi-Machado CM, Polizello AC, Azzolini AE, Lucisano-Valim YM. The infl uence of antibody functional affi nity on the effector functions involved in the clearance of circulating immune complexes anti-BSA IgG/BSA. Immunol Invest 1999 ; 28 ( 2-3 ): 89-101.